All In Biotech

Drug Trial Radar · NCT05934526

Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Inhalation of Seralutinib for the Treatment of Pulmonary Arterial Hypertension (PAH)

Last checked: Nov 20, 2026Latest source record: May 19, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedPivotal-lookingPhase 3. Randomized with 390 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

390

Actual

Start

Dec 28, 2023

Primary completion

Nov 27, 2025

Study completion Dec 22, 2025

Sponsor

Lead sponsor
GB002, Inc.Industry
Sponsor type
Industry
First posted
Jul 7, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary objective of the study is to determine the effect of seralutinib on improving exercise capacity in subjects with WHO Group 1 PAH who are FC II or III. The secondary objective for this trial is to determine time to clinical worsening.

Conditions

  • Pulmonary Arterial Hypertension

Interventions

  • PlaceboDrug

    Matching capsule containing placebo

  • SeralutinibDrug

    Capsule containing seralutinib

  • Generic Dry Powder InhalerDevice

    Generic dry powder inhaler for seralutinib or placebo delivery

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change in distance achieved on the six-minute walk test (6MWT), six-minute walk distance (Δ6MWD) from baseline to Week 24Time frame: Baseline to 24 weeks

Locations

166 sites in 31 countries. Site status is shown where the registry gives one.

  • University of Alabama at Birmingham

    Birmingham, Alabama

  • Valley Advanced Lung Diseases Institute

    Fresno, California

  • Keck Medical Center of USC

    Los Angeles, California

  • Dept of Veterans Affairs Greater Los Angeles Healthcare System

    Los Angeles, California

  • University of California, Irvine Medical Center

    Orange, California

  • UC Davis Health

    Sacramento, California

  • Stanford Healthcare

    Stanford, California

  • Winchester Center for Lung Disease

    New Haven, Connecticut

  • The George Washington University Medical Faculty Associates

    Washington D.C., District of Columbia

  • University of Florida Clinical Research Center

    Gainesville, Florida

  • Mayo Clinic

    Jacksonville, Florida

  • Piedmont Physicians Pulmonary & Sleep Medicine of Buckhead

    Atlanta, Georgia

  • Emory University

    Atlanta, Georgia

  • Northside Hospital Laboratory - Atlanta

    Atlanta, Georgia

  • UI Health Hospital

    Chicago, Illinois

  • University of Iowa Hospitals & Clinics

    Iowa City, Iowa

  • University of Kansas Medical Center

    Kansas City, Kansas

  • Norton Hospital

    Louisville, Kentucky

  • Tufts Medical Center

    Boston, Massachusetts

  • Massachusetts General Hospital

    Boston, Massachusetts

  • University of Michigan

    Ann Arbor, Michigan

  • M Health Fairview University of Minnesota Medical Center - East Bank

    Minneapolis, Minnesota

  • University of Missouri

    Columbia, Missouri

  • Washington University School of Medicine

    St Louis, Missouri

  • University of Nebraska Medical Center

    Omaha, Nebraska

  • University of New Mexico Health Sciences Center

    Albuquerque, New Mexico

  • NYU Langone Health

    New York, New York

  • University of Rochester Medical Center

    Rochester, New York

  • UNC Hospitals

    Chapel Hill, North Carolina

  • Duke University Medical Center - Duke South

    Durham, North Carolina

  • University of Cincinnati Medical Center

    Cincinnati, Ohio

  • Cleveland Clinic Foundation

    Cleveland, Ohio

  • INTEGRIS Cardiovascular Physicians, LLC

    Oklahoma City, Oklahoma

  • Oregon Health & Science University

    Portland, Oregon

  • The Hospital of the University of Pennsylvania

    Philadelphia, Pennsylvania

  • Temple Heart and Vascular Institute (Outpatient Clinic)

    Philadelphia, Pennsylvania

  • UPMC Presbyterian Hospital

    Pittsburgh, Pennsylvania

  • Rhode Island Hospital

    Providence, Rhode Island

  • Medical University of South Carolina - Nexus Research Center

    Charleston, South Carolina

  • UT Southwestern Medical Center

    Dallas, Texas

Showing 40 of 166 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.